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Abstract
Background: Browne et al. [Browne, MacCallum, Kim, Andersen, Glaser: When fit indices and
residuals are incompatible. Psychol Methods 2002] employed a structural equation model of
measurements of target cell lysing by natural killer cells as an example purportedly demonstrating
that small but statistically significant ill model fit can be dismissed as "negligible from a practical point
of view".
Methods: Reanalysis of the natural killer cell data reveals that the supposedly negligible ill fit
obscured important, systematic, and substantial causal misspecifications.
Results: A clean-fitting structural equation model indicates that measurements employing higher
natural-killer-cell to target-cell ratios are more strongly influenced by a progressively intrusive
factor, whether or not the natural killer cell activity is activated by recombinant interferon γ (rIFN
γ). The progressive influence may reflect independent rate limiting steps in cell recognition and
attachment, spatial competition for cell attachment points, or the simultaneous lysings of single
target cells by multiple natural killer cells.
Conclusions: If the progressively influential factor is ultimately identified as a mere procedural
impediment, the substantive conclusion will be that measurements of natural killer cell activity
made at lower effector to target ratios are more valid. Alternatively, if the individual variations in
the progressively influential factor are modifiable, this may presage a new therapeutic route to
enhancing natural killer cell activity. The methodological conclusion is that, when using structural
equation models, researchers should attend to significant model ill fit even if the degree of
covariance ill fit is small, because small covariance residuals do not imply that the underlying model
misspecifications are correspondingly small or inconsequential.
Background
Browne, MacCallum, Kim, Andersen and Glaser [1]
employed a measurement model of natural killer cell lysis
as an example of testing structural equation models. Their
model failed to fit the data, though the authors judged the
degree of covariance ill fit to be "negligible from a
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practical point of view"[1]. One of us (Hayduk) was
engaged in a SEMNET [2] discussion of model fit testing,
and objected to the close-yet-failing structural equation
model being described as adequate. We re-examined the
relevant measurement procedures and subsequently
located a cleanly fitting model which provided evidence
of important systematic effects coordinated with the effec-
tor to target ratios used during the measurement of natu-
ral killer (NK) cell activity. This article summarises the
Browne et al. [1] data, discusses the clean-fitting model,
and investigates alternative models in an attempt to better
characterise the factor that produces the progressive meas-
urement interference.
Methods
The immune system measurements
Browne et al. [1] analysed the correlation matrix for eight
measures of immune system function of 72 females with
breast cancer, recorded during investigation of the physi-
ological consequences of a psychological intervention
[3,4]. Four 51Cr-release measures of natural killer cell lysis
were obtained using effector (NK cell) to target cell (K562
human myeloid cell) ratios of 100:1, 50:1, 25:1 and
12.5:1. Following Browne et al. [1] we designate these
measures by their effector to target (E:T) ratios, NK100,
NK50, NK25 and NK12 respectively. Similarly, natural
killer cell lysis measured in the presence of recombinant
interferon gamma (rIFNγ) using E:T ratios of 50:1, 25:1,
12.5:1 and 6.25:1, are designated IFN50, IFN25, IFN12,
and IFN6 respectively. Lower E:T ratios are used in the
presence of rIFNγ because rIFNγ increases NK cells' ability
to rupture target cells.
The correlations reported in Browne et al.'s [1] Table 1
indicate that the four NK measures correlate highly with
one another (average r = 0.852), and that the four rIFNγ
enhanced NK measures also correlate highly with one
another (averaging 0.960). However, the low correlations
between the sets of NK and rIFNγ measurements (averag-
ing only .111) indicate that the two sets of measurements
reflect relatively distinct aspects of natural killer cell func-
tioning. Browne et al. [1] viewed this as justifying the use
of an exploratory two-factor model (Figure 1) which,
unfortunately, was significantly inconsistent with the data
Table 1: Maximum likelihood estimates for the Browne et al [1] two-factor, and the progressive impact, models
Browne et al.[1] Model++ Progress ive Impact Model
NK 
Activity 
Factor
IFN 
Activity 
Factor
Indicator 
R2+++
NK 
Activity 
Factor
IFN 
Activity 
Factor
NK 
Progressi
ve Factor
IFN 
Progressi
ve Factor
Indicator 
R2
Proportion of 
indicator variance 
explained by NK 
Activity Factor
Proportion of 
indicator variance 
explained by IFN 
Activity Factor
NK100 .842 .003 .709 .705** -- -80.1** -- .958 .50 --
NK50 .936 -.005 .876 .851** -- -50.0+ -- .918 .72 --
NK25 .943 .015 .892 .920** -- -25.0+ -- .874 .85 --
NK12 .964 -.013 .927 .922** -- -12.5+ -- .995 .98 --
IFN50 .030 .942 .893 -- .897** -- -50.0+ .972 -- .80
IFN25 -.019 .996 .988 -- .977** -- -25.0+ .996 -- .95
IFN12 .005 .995 .990 -- .988** -- -12.5+ .988 -- .98
IFN6 -.018 .991 .977 -- .944** -- -6.25+ .990 -- .99
Factor 
Variance
1.0+ 1.0+ 1.0+ 1.0+ .000069§*
*
.000069§
**
+ a fixed coefficient
* beyond 2 standard errors
** beyond 3 standard errors
§ constrained to be equal
++ Identifying Browne et al's [1] exploratory two-factor model requires excluding one indicator from loading on each factor. Repeated emails to 
both Browne and MacCallum were unable to elicit a statement of precisely which two loadings had been set to zero. There are 16 different ways of 
excluding one IFN indicator from loading on the NK activity factor and simultaneously excluding one NK indicator from the INF activity factor (see 
dashed loadings in Figure 1). The loadings in column 1 and 2 are the average of the estimated loadings calculated across these 16 exclusion 
possibilities. Each of the 16 models provided a χ2 = 103.8, df = 13, p = 0.000, with the slight difference from the reported fit being easily attributed 
to the three figure accuracy of the correlations published in Browne et al.[1].
+++ These values are for the version of the Browne et al. [1] model that excludes the effects leading from the NK latent to IFN6 and from the IFN 
latent to NK100 for identification of the model.BMC Medical Research Methodology 2005, 5:1 http://www.biomedcentral.com/1471-2288/5/1
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(χ2 = 103.59, degrees of freedom (df) = 13, and probabil-
ity p < 10-15). The small but significant residual differences
between the data correlations and the correlations
implied by the two-factor model were dismissed by
Browne et al.[1] as "negligible from a practical point of
view". SEMNET discussion of this model prompted Hay-
duk to investigate whether some unrecognized measure-
ment feature was producing the significant, even if
seemingly slight, ill fit.
Andersen, Farrar, Golden-Kreutz, Kutz, MacCallum,
Courtney & Glaser [3] provide a description of the reason-
ably standard procedures used to obtain the Browne et al.
[1] data. Peripheral blood leukocytes (PBLs) were
obtained from 60 mL of venous blood, counted so that a
known number of PBLs could be suspended in medium
and incubated with either additional medium or addi-
tional medium plus rIFNγ. K562 target cells (a human
myeloid cell line sensitive to NK cell activity) were
labelled with 51Cr and aliquoted with the effector cells
(either the NK, or the rIFNγ activated NK cells) in the
ratios reported above. The cell mixture was centrifuged to
ensure cell surface contact, and incubated to provide an
opportunity for the NK cells to bind and rupture the target
cells, thereby releasing the radioactive target cell cyto-
plasm. Gamma radioactivity of the supernatant collected
from a second centrifuging indicated the effectiveness of
the NK or rIFNγ-activated-NK cells at lysing the target
cells, with larger measurements corresponding to more
effective NK cell activity.
An alternative model
Browne et al. [1] modelled the measurements made at the
various E:T ratios as replicate measurements. Hayduk sus-
pected that the progressively varying E:T ratios might have
introduced systematic measurement interference. Higher
E:T ratio measurements might result in systematically less
NK cell effectiveness, not because of differential NK
The Browne, MacCallum, Kim, Andersen and Glaser (2002) two-factor model Figure 1
The Browne, MacCallum, Kim, Andersen and Glaser (2002) two-factor model The dashed arrows correspond to 
weak effects. Statistical identification of the model's coefficients requires exclusion of one dashed arrow from each factor as 
explained in Table 1.
IFNȖ-Induced
NK-Cell Activity 
Factor
Instrinsic
NK Cell Activity
Factor
   NK100    NK50    NK25    NK12              IFN50    IFN25    IFN12   IFN6BMC Medical Research Methodology 2005, 5:1 http://www.biomedcentral.com/1471-2288/5/1
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activity but because of some progressive complication
subsumed within the measuring procedures. For example,
higher E:T ratios might decrease the ability of NK cells to
contact and lyse target cells due to competition for cell
surface contact area. Or multiple NK (or other leukocyte)
cells might block some NK cells from attaining sufficient
surface contact with the K562 cells, and thereby render
them seemingly ineffective – not due to lack of potency,
but as a result of competition for surface contact. Alterna-
tively, the lysing of a single target cell by multiple attached
NK cells, which becomes more likely at higher E:T ratios,
might make the NK cells appear comparatively ineffective
on a "per cell" basis. The amount of target cell cytoplasm
released per effector cell would be disproportionately
small because multiple NK cells might have to "share the
credit" for participating in lysing a single target cell, and
not because of lower NK cell effectiveness. Competition
for attachment sites, and multiple simultaneous NK
attacks on single targets, would increase as the effector NK
cells more radically outnumbered target cells, and hence
should be more pronounced at higher E:T ratios.
These considerations led to the model of E:T-progressive
interference depicted in Figure 2. This model postulates
two latent factors, paralleling the factors in the Browne et
al. [1] model (an NK activity factor causing the NK indica-
tors' values, and an rIFNγ activity factor causing the IFN
indicators' values), plus two progressively interfering fac-
tors (one spanning the NK indicators, the other spanning
the IFN indicators). The effects of the interfering factors
are progressive in proportion to the E:T cell ratios, and
negative because we anticipated progressive reduction in
the per-cell radioactivity readings, as discussed above. The
negative signs are purely for ease of expression, since pro-
gressive positive values result in an equivalent model that
merely interchanges the high and low ends of the under-
lying factor's scale. One progressive factor is postulated as
acting within each measurement series, and these factors
are postulated as being independent of one another, and
also independent of the true scores on the NK and rIFNγ-
enhanced activity factors. The variances of the two meth-
ods factors were constrained to be equal because the
procedural similarity in the measurement series initially
led us to suspect that routine within-series laboratory var-
iations might propagate proportionally. We originally saw
no reason to anticipate that rIFNγ would alter the mecha-
nisms initially postulated as providing the progressive
interference. Later consideration of multiple potential
mechanisms led us to investigate the possibility of vari-
ance differences, as reported below.
The model with progressively influential factors Figure 2
The model with progressively influential factors
  Progressive                                                     Progressive
 NK Methods                                                    IFN Methods
     Factor                             Factor
            -100             -6.25
(-80.1)       -50              -12.5
         -25       -25 
           -12.5               -50 
                  NK100    NK50    NK25    NK12       IFN50    IFN25    IFN12    IFN6 
Intrinsic
NK-Cell Activity
Factor
IFNȖ-Induced
NK-Cell Activity
FactorBMC Medical Research Methodology 2005, 5:1 http://www.biomedcentral.com/1471-2288/5/1
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Results
This model contains 18 estimates: four loadings of the NK
indicators on the NK activity factor, four loadings of the
IFN indicators on the rIFNγ activity factor, the correlation
between the two activity factors (whose variances are fixed
at 1.0), eight measurement error variances (one per indi-
cator), and the single variance applied or assigned to both
the separate interfering factors. This model fits, but a neg-
ative measurement error variance estimate for NK100 sug-
gested a ceiling had been reached for the largest E:T ratio.
Freeing the loading for the NK100 indicator results in
clean fit (χ2 = 11.97, df = 17, p = 0.802) and an estimate of
-80.1, rather than a strictly proportional value of -100. The
alternative of constraining the offending measurement
error variance to be non-negative while maintaining the -
100.0 loading, also results in a fitting model (χ2 = 14.72,
df  = 18, p  = 0.681) having very similar estimates, so
whether the interfering effects are "nearly proportional"
or "strictly proportional" is equivocal. The progressive
and nearly-proportional model (see Figure 3 for program
details) provides the estimates in Table 1. The clean fit of
this model convinces us that something is indeed interfer-
ing with the NK cell activity measurements, and "that
something" is acting progressively and nearly in propor-
tion to the E:T ratios.
Further characterising the interfering entity
Additional models were estimated in attempts to further
characterize the entity providing the progressive interfer-
ence. The lowest inter-item correlations, and the greatest
ill-fit of the Browne et al. [1] model, appeared for the NK
measurements, so we checked whether a single methods
factor spanning only the NK measures would be consist-
ent with the data. This model is similar to Figure 2 model,
except that the progressive methods factor spanning the
IFN measures is eliminated. This model fails significantly
(χ2 = 62.5, df = 17, p < 0.001) and thereby informs us that
even the seemingly cleaner IFN measurements are influ-
enced by some progressively interfering factor.
Are two similar, yet separate, factors required for the NK
and IFN measurement series, or might it be possible that
one E:T-coordinated progressive factor spans all eight
measurements? That is, could the progressive interfering
factor be something common to an individual, rather
than something set for each individual once within the
NK measurement series and reset independently (or be
some other interference) within the IFN measurement
series? To check this, we specified a model having a single
progressive methods factor leading to all eight indicators.
The same E:T ratio dictated loadings were used, and the
NK100 loading freed. This model also fails convincingly
(χ2 = 75.5, df = 17, p < 0.001) and thereby speaks against
the progressive entity being something connected to each
case as a whole. That is, no single feature common to the
full set of measurements (e.g. the time of blood sampling,
or the person's age, or their cancer progression, or mis-
taken cell counts), could be progressively applied across
both measurement series to account for the data. Such fac-
tors might constitute the entity spanning the items within
one series, but the other measurement series would have
to be progressively influenced by something else.
Together, these two failing models require that the entities
providing the progressive interference are features con-
nected exclusively to either the NK series or the IFN meas-
urement series, or are something that is set independently
within each of the NK and IFN measurement series for any
given case.
We next attempted to check the requirement for equal
progressive-factor variance incorporated in the Figure 2
model. Attempting to estimate a separate variance for
each progressive factor resulted in signs of under-identifi-
cation, and hence these data should be heard as being
consistent with, but not necessarily as requiring, equal
variances for the progressively interfering factors.
In response to the comments of Reviewer-2 (Professor
Mulaik), we attempted to check whether the progressive
methods factors were necessarily independent of the
LISREL (Joreskog and Sorbom [6]) program syntax for the  Figure 2 progressive factors model Figure 3
LISREL (Joreskog and Sorbom [6]) program syntax 
for the Figure 2 progressive factors model
Title Progressive Factors,  One Loading Free 
DA NI=8 NO=72 MA=CM  
CM SY 
{Insert correlations from Browne et al. [1] Table 1 here}  
MO NY=8 NX=0 NE=4 NK=0 LY=FU,FI BE=FU,FI PS=SY,FI 
TE=SY,FI 
VA 1.0 PS(1,1) PS(2,2) 
FR PS(2,1) 
FR  LY(1,1) LY(2,1) LY(3,1) LY(4,1) 
ST .9 LY(1,1) LY(2,1) LY(3,1) LY(4,1) 
FR LY(5,2) LY(6,2) LY(7,2) LY(8,2) 
ST .95 LY(5,2) LY(6,2) LY(7,2) LY(8,2) 
FR  LY(1,3) 
ST  -100.  LY(1,3) 
VA  -50.  LY(2,3) 
VA  -25.  LY(3,3) 
VA -12.5 LY(4,3) 
VA  -50.  LY(5,4) 
VA  -25.  LY(6,4) 
VA -12.5 LY(7,4) 
VA -6.25 LY(8,4) 
FR PS(3,3) PS(4,4) 
EQ PS(3,3) PS(4,4) 
ST .0000001 PS(3,3) PS(4,4) 
FR TE(1,1) TE(2,2) TE(3,3) TE(4,4) TE(5,5) TE(6,6) TE(7,7) TE(8,8) 
OU  ML AL ND=6BMC Medical Research Methodology 2005, 5:1 http://www.biomedcentral.com/1471-2288/5/1
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corresponding true NK activity factors, by freeing the cor-
responding covariances (which were constrained to be
equal). This also resulted in signs of underidentification.
Hence these data should be heard as being consistent
with, but not necessarily as demanding, the independence
of the methods factors from the corresponding true NK
activity factors. Forcing even a modest correlation
between true NK activity and progressive methods factors
results in substantial suppression of effects, and
standardized effects exceeding 1.0 – which is not "impos-
sible" but which would certainly "confront" anyone
inclined to postulate a coordination between true NK
activity and the progressive methods factors on substan-
tive rather than "exploratory-statistical" grounds.
It might be tempting to interpret these underidentified
models as signs of insufficient power due to the rather
small N of 72 provided by Browne et al. [1] but we think
it would be more reasonable to see these underidentified
models as artifacts of the limited variety of variables in the
Browne et al. [1] data. The N of 72 provided sufficient
power to speak strongly against the Browne et al. model,
and sufficient power to speak strongly against several of
the alternative models we considered above. The models
that became underidentified did so largely because the
structure of these models resulted in the freed coefficients
having no unique (freed-coefficient dependent) implica-
tions which could potentially be found to be more/ less
consistent with the data. Anyone wishing to investigate
the ideas contained in the underidentified models would
be better advised to add a wider variety of variables into
their data and model structure, rather than merely
increasing N while maintaining the current style of meas-
urements and models.
The parameter estimates
We have basically two sets of estimates to consider: the
estimates for the failing Browne et al. [1] two-factor model
(Figure 1, and Table 1 columns 1, 2, and 3), and the esti-
mates for the fitting progressive measurement interference
model (Figure 2, and Table 1 columns 4 through 10). The
loadings of the measures on the NK-activity and IFN-activ-
ity factors, namely the estimated effects of "true" NK-activ-
ity and "true" IFN-activity on their respective sets of four
measures, differ importantly between these models. The
Browne et al. [1] estimates are relatively uniform and
large, in contrast to the loadings for our fitting model
which display a definite progression from smaller to larger
loadings as one moves from higher to lower E:T ratio
measurements.
It is no coincidence that the weakest loading estimates
appear where the progressive interference is the greatest,
namely for the highest E:T ratio measurements. As more
variance in a measure is accounted for by the progressively
interfering factor, less variance is left to be accounted for
by the true NK or IFN activity factor. According to the fit-
ting progressive model, only about half the variance in the
NK100 indicator arises from true variability in NK activity,
while the "other half" of the variance arrives primarily
from the progressive methodological factor, with a mini-
mal amount of error variance contributed by features
unique to the NK100 measurement.
Given that the latent variables have variance 1.0, the vari-
ance the NK activity factor contributes to an NK indicator
can be calculated as the square of the appropriate loading.
The Browne et al. [1] model, therefore, claims true NK
activity contributes .71, .88, .89 and .93 to the variance in
NK100, NK50, NK25 and NK12 respectively. In contrast,
squaring the effects leading from our NK activity factor to
the indicators provides values of .50, .72, .85 and .98.
These values make it clear that Browne et al.'s [1] over-
looking of the progressive methodological interference
results in their model claiming that too large a portion of
the variance in the high E:T ratio measures arises from true
NK activity, while too small a portion of the variance in
the lowest E:T ratio measure arises from true NK activity.
(A similar, but less pronounced, pattern appears if corre-
sponding calculations are made for the contribution of
IFN activity to the IFN indicators.) That is, the bias in the
Browne et al. [1] estimates systematically obscures the
substantial and progressively stronger measurement of
true NK activity by the lower E:T ratio measurements,
whether viewed from the perspective of the estimates
themselves or the variance accounted for by those
estimates.
The squared multiple correlation coefficient R2 (column 3
of Table 1) is usually interpreted as a "proportion of
explained variance" but the above observations require
that we reconsider this for the Browne et al. model. The
Browne et al. model fails to fit with the data, and hence
confronts evidence of causal misspecification, and it also
confronts evidence of bias in its estimates. Is it reasonable
to claim that a misspecified model containing biased esti-
mates "explains" or "accounts for" variance in the indica-
tors? Even biased estimates can be put through the
mathematical formula providing model-implied vari-
ances and R2 (see Hayduk [5] pages 106–116, 184; and
notice that the first four entries in column 3 correspond
closely to the model-implied variance contributions
reported in the preceding paragraph), but can mathemat-
ically-clean manipulations of biased, non-world-match-
ing, coefficients be reasonably described as providing an
"account of" or an "explanation for" indicator variances?
That is, if biased estimates from a wrongly specified model
are put through the perfectly-adequate mathematics pro-
viding variance implications, are the resultant variances
"explained" or "accounted for"?BMC Medical Research Methodology 2005, 5:1 http://www.biomedcentral.com/1471-2288/5/1
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Our view is that claims to "explaining variance" and
"accounting-for variance" are rendered unconvincing if
there is evidence indicating the model that supposedly
provides the "explanation or account" fails to correspond
to a proper representation of the external world. Hence,
we view the R2 values in column 3 of Table 1 as properly
calculated, yet fundamentally dubious, because the calcu-
lations are based on biased estimates from a misspecified
model. These R2 values constitute "dubiously explained or
accounted-for proportions" of indicator variances.
Our Figure 2 model does not confront evidence of mis-
specification, and hence it would seem that the R2 values
in column 8 of Table 1 could be more comfortably
described as proportions of explained variance. But these
R2 values have a different kind of uncertainty attached to
them because the identity of the progressive latent varia-
ble is currently unascertained, as we discuss in the next
section. The final two columns of Table 1 provide the pro-
portions of variance in the indicators that are most confi-
dently "explained" because these values come from a
model that fits the data, and report the proportions of var-
iance originating in latent variables whose identity is most
confidently known.
Let us next consider the loading estimates from the per-
spective of the correlations between two pairs of indica-
tors, specifically the correlation between the NK100 and
NK50 measurements (0.902) and the correlation between
NK25 and NK12 (0.930). The Figure 2 model accounts for
the 0.902 NK100-NK50 correlation via the action of two
common causes: the true NK activity factor which
contributes (0.705)(0.851)(1.0) (namely, the product of
two loadings and the variance of the relevant common
factor; Hayduk [5] pages 26, 106), and the progressively
interfering factor which contributes (-80.1)(-
50.)(0.0000695), for an overall correlation of 0.600 +
0.278 = 0.878 (with the remaining 0.023 residual being
within the range of sampling fluctuations). The 0.930
NK25-NK12 correlation is similarly accounted for by a
true NK activity contribution (0.920)(0.992)(1.0) and a
progressive methods factor contribution (-25.)(-
12.5)(0.0000695), for a total of 0.912 + 0.022 = 0.934
(which leaves a residual of -0.004).
Notice that while the correlations are not radically differ-
ent (0.902 vs 0.930) the contribution to the correlation
provided by the causal actions of true NK activity differ
substantially (0.600 versus 0.912). A substantial portion
of the correlation between the NK100 and NK50
measurements is being provided by the progressively
interfering factor, and when this is taken into account,
there is a substantial reduction in the degree of coordina-
tion that can be attributed to both these measures causally
responding to true NK activity. This is the classic distinc-
tion between reliability and validity. The NK100 and
NK50 measures seem to possess substantial reliability
(the basic 0.902 correlation) but much less validity since
a substantial portion of the stability, or inter-measure reli-
ability, is arising from a stable, and in this instance pro-
gressively-influential interfering entity.
The small variance estimate for the progressively interfer-
ing factor (0.0000695) is partially an artifact of the large
absolute values used in setting the proportional methods
effects (-100, -50, -25, etc.). If each of these effects is
rescaled by dividing by 100, the effects become -1.0, -0.5,
-0.25, -0.125 for NK and -0.5, -0.25, -0.125 and -0.0625
for IFN, and the proportionality of the effects is preserved
but the estimated variance of the progressive factor is
increased 1002 fold, to 0.695, while the other estimates
remain unchanged.
One additional model estimate is worth noting. The Fig-
ure 2 model permits a correlation between the NK and
IFN activity factors, but the corresponding estimate is
small (0.090) and insignificant. The insignificance of this
correlation implies that it is reasonable to view all four of
the factors in Figure 2 as being basically independent of
one another. Two independent entities account for the NK
measurements while two additional entities that are inde-
pendent of one another and also independent of the NK-
measurement-producing entities account for the IFN
measurements.
What is producing the progressive interference?
Let us first consider features capable of producing progres-
sive interference within each series. Multiple simultane-
ous lysings of a single target cell provide several
possibilities. With higher E:T ratios it becomes progres-
sively more likely that any given target cell will be simul-
taneously attacked by more than one NK cell. The 51Cr
"credit" for having lysed a target cell will be shared among
the multiple attacking NK cells, and hence will reduce the
seeming per-NK-cell effectiveness of the NK cells. Individ-
ual differences in the mechanisms of cell recognition,
strength of attachment, delay in NK cytoplasmic reorgan-
ization, or energy supply, which are separate from what-
ever rate-limit constitutes "true NK cell activity", could
provide individual differences constituting the variance in
the "progressive factor". From this perspective, the inde-
pendent progressive factor within the rIFNγ series might
constitute a rIFNγ induced switch to a different rate-limit-
ing component associated with multiple NK lethal
attachments.
Alternatively, the progressive interference might arise
from the blocking of some effector NK cells by physical
presence of scrimmage-line NK or lymphocyte cells. If an
NK cell is obstructed or delayed in making contact with aBMC Medical Research Methodology 2005, 5:1 http://www.biomedcentral.com/1471-2288/5/1
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target cell by: a) the physical obstruction created by other
cells between this NK cell and the target, or b) the NK cell
wasting time discovering that the adhered cell is merely
another NK or lymphocyte cell rather than a valid target,
this progressively reduces the apparent 51Cr-producing
effectiveness of that cell – again a phenomena which
should coordinate with the E:T ratio.
The "multiple simultaneous attacks" and "blocking" sce-
narios might be supplemented by individual differences
in the ability of NK cells to lyse multiple sequential tar-
gets. At higher E:T ratios fewer pristine targets are available
and hence fewer NK cells have the opportunity to deliver
second-lethal-doses, or may end up sharing their second-
dose credits. Or, if lethal doses from multiple NK cells
reduce the time to ion-gradient-induced cell membrane
rupture, multiple-simultaneous-NK activity might instan-
tiate the positive-valued model reported above.
Yet other possibilities arise from NKT-cells and T-cell sup-
pression of NK cells. At higher E:T ratios, there may be
greater suppression of NK cells by higher concentrations
of suppressor chemical signals. Similarly, NKT-cells may
become progressively activated or deactivated by E:T-con-
centration-dependent signals from other T cells in the
medium.
If an individual's NK cells are not uniformly active, but
rather display a within-individual gradient of activity
(some NK cells being more active than others), and if this
gradient is set independently of the features underlying
"true NK activity" this would provide another form of
explanation. Yet another possibility arises from the uptake
of  51Cr by NK cells or other lymphocytes following its
release from lysed target cells. At higher E:T ratios more
cells are present to re-uptake 51Cr released from lysed tar-
get cells, and hence less 51Cr will appear in the centrifuged
supernatant. Clearly, there are multiple possibilities for
what might be providing the E:T ratio coordinated varia-
tions in lysing ability, and any independent pairing of
these possibilities potentially constitute the interference
in the NK and IFN measurement series.
Discussion and Conclusions
This study was prompted by fortuitous use of NK cell
activity measurements in a debate over the testing of struc-
tural equation models. According to Browne et al. [1],
even though the two-factor model of NK and rIFNγ activ-
ity they proposed (Figure 1) was significantly at odds with
their correlation data, the residual differences were small
enough to be "negligible from a practical point of view".
Our view was that the small size of the correlation residu-
als did not imply that the reason for the ill fit was corre-
spondingly small or unimportant, and this prompted our
reexamination of what might be producing the ill fit.
These reconsiderations led to the Figure 2 model in which
the measurements reflect both the "true" degree of NK or
rIFNγ induced NK cell activity along with the influences of
features that progressively impact these measurements in
proportion to the E:T ratios. Introducing a progressive,
and nearly proportional, interfering factor within each
measurement series resulted in a cleanly fitting model
whose residuals are small enough to be easily attributable
to chance sampling fluctuations, and whose estimates
imply that true NK or rIFNγ-induced activity is most accu-
rately measured at low E:T ratios. The impact of the pro-
gressively interfering feature is sufficiently pronounced
that at the highest E:T ratio of 100 only half of the variance
in the NK measurement can be attributed to "true" NK
activity. The "other half" of the variance in this
measurement seems to arise primarily from the progres-
sive factor. Thus the small residuals of the Browne et al.
[1] model seem to have obscured major influences in the
data. Consideration of the methodology underlying the
NK and rIFNγ measurements locates several possible iden-
tities for the progressively effective feature, including mul-
tiple simultaneous lysings, cell occlusion or blockage,
within-individual NK activity gradients, and 51Cr
reuptake.
One important consequence of the fitting model is that it
provides evidence indicating the lowest E:T measures pro-
vide the most valid measures of NK and rIFNγ induced lys-
ing activity. The NK or rIFNγ measurements made at
higher E:T ratios correlate highly with one another, but a
substantial portion of these correlations appears to result
from the progressive interfering factor and not "true" NK
and rIFNγ activity. The higher E:T ratio measures remain
reliable in the sense of being stable, but they are not as
valid as measurements of "true" lysing activity. Given that
nearly half the variance in the NK100 measurements is
connected to the progressive factor, we have encountered
something that is substantial and probably routinely
noticed in practice, and is just being mislabeled or
overlooked.
A second important consequence of the Figure 2 model is
that it suggests that there may exist some "third-causal-
source" of lysing ability. If we think of natural lysing abil-
ity as a first source, and rIFNγ activation as a second source
of lysing ability, the progressive factor may constitute a
third and independent causal source. That is, just as rIFNγ-
induced NK cell activity can therapeutically supplement
NK activity, whatever constitutes the progressive factor
may also be able to therapeutically supplement both the
NK and rIFNγ-induced activities. If the interfering factors
turn out to be something like blocking of access to the
target cells by other cell bodies, this will be viewed as
merely "the reason" lower E:T ratios provide more trust-
worthy measurements. But if the interfering factor turnsPublish with BioMed Central    and   every 
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out to be something connected to a chemical concentra-
tion (e.g. magnesium stores) then this could constitute a
potential third and independent causal route to therapeu-
tic enhancement of killer cell activity.
The fact that the progressive factors are tightly connected
to E:T ratios makes differential NK activity at various E:T
ratios an obvious point of investigative departure. The fact
that one of the progressive factors contributes about half
the variance in the highest E:T ratio NK measurements
implies we are not confronting issues at the limits of
measurement, but rather are confronting issues of meas-
urement confounding. Incorporating measures of varia-
bles connected to the "candidate explanations" in an
expanded version of Figure 2 could effectively screen the
explanatory options.
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